Kezar Life Sciences, Inc.KZRNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P100
Near historical high
vs 2Y Ago
4.2x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q3 202519.75%
Q2 202517.19%
Q1 202518.24%
Q4 20241.75%
Q3 20246.14%
Q2 20241.38%
Q1 202416.52%
Q4 2023-11.26%
Q3 20234.69%
Q2 2023-9.22%
Q1 2023-22.41%
Q4 2022-5.85%
Q3 2022-15.95%
Q2 2022-2.80%
Q1 2022-12.59%
Q4 20212.73%
Q3 2021-11.45%
Q2 20210.30%
Q1 2021-17.89%
Q4 20204.18%
Q3 2020-17.23%
Q2 20205.96%
Q1 2020-4.81%
Q4 2019-3.26%
Q3 2019-3.48%
Q2 2019-12.59%
Q1 2019-29.30%
Q4 2018-2.59%
Q3 20189.87%
Q2 2018-36.65%
Q1 2018-110.25%
Q4 2017-10.36%
Q3 2017-16.53%
Q2 201716.66%
Q1 20170.00%